Siam Modified Starch Co., Ltd. proudly announces its achievement of the EXCiPACT certification from SGS (Thailand), an internationally recognized standard for the manufacturing of pharmaceutical excipients. This milestone reflects the company’s unwavering commitment to quality, safety, and reliability in every stage of its production process. It also demonstrates the company’s readiness to meet the growing demands of the global pharmaceutical and healthcare industries.
Understanding EXCiPACT and Its Importance
EXCiPACT is a globally acknowledged certification that covers Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) for pharmaceutical excipients. Its purpose is to ensure that products are manufactured and distributed under strict quality and safety requirements, in line with international regulatory expectations. Achieving this certification is a significant step for any company, as it not only validates compliance with global standards but also enhances competitiveness in international markets where stringent regulations are the norm.
Certificate Presentation and Key Figures
On this occasion, Mr. Pongsak Namthanee, Certification Manager for Strategic Products from SGS (Thailand), presented the EXCiPACT certificate to Mr. Natachai Wanglee, Managing Director, and Mr. Werawat Lertwanawatana, Chief Executive Officer of Siam Modified Starch Co., Ltd., The certificate presentation ceremony symbolizes the company’s dedication to excellence and its strategic vision to become a global leader in excipient manufacturing. This achievement is not just a recognition of past efforts but a commitment to future growth and innovation.
Impact of EXCiPACT Certification on Future Growth
The EXCiPACT certification strengthens customer confidence and builds trust among partners, ensuring that Siam Modified Starch is recognized as a reliable supplier in the pharmaceutical industry. It also opens doors to new opportunities in highly regulated markets such as the United States and Europe, where compliance with international standards is mandatory. By meeting these requirements, Siam Modified Starch positions itself as a competitive player capable of supporting the global healthcare sector’s rapid expansion.
Vision and Commitment Moving Forward
Siam Modified Starch remains committed to continuous improvement and innovation. The company aims to maintain the highest safety and quality standards while developing new solutions that meet the evolving needs of the pharmaceutical and healthcare industries. This achievement marks the beginning of a new chapter in the company’s journey toward global leadership, reinforcing its role as a trusted partner in delivering high-quality excipients worldwide.
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
238 TRR Tower, 19th-21st Floor, Naradhiwas Rajanagarindra Road,
Chong Nonsi, Yannawa, 10120,
Bangkok, Thailand